Skip to main content
Caplight Logo









CoroLogic

CoroLogic

Private
South KoreaHealthcare & Life Scienceshttps://corologic.io/

Last Round

Seed

Sep 14, 2026

Momentum

Top 10%

of companies Caplight tracks

Company Overview

CoroLogic operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Seed round in September 2026.

CoroLogic is a medical AI company that develops software solutions to reduce radiation exposure during cardiovascular angiography procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CoroLogic Comparables

Compare CoroLogic with similar companies based on industry and business-model similarity.

CoroLogic comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AlgoMedica
69%
Cydar Medical
69%
Caristo Diagnostics
68%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CoroLogic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 14, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

CoroLogic Investors

Notable investors and investment history

CoroLogic investors
InvestorRounds
Kakao VenturesSeed
Seoul National University Technology HoldingsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 14, 2026

    Seed round raised with Kakao Ventures and SNU Tech Holdings.

Book a demo to see all signals

For institutional investors. Book with your work email.

CoroLogic Filings

Explore SEC and related filing metadata, where available.

CoroLogic filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CoroLogic's valuation, stock price, and market status.

Is CoroLogic a public or private company?

CoroLogic is a private company.

What is the current stock price of CoroLogic?

CoroLogic is a private company, so its shares have no public market price. Caplight tracks CoroLogic's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CoroLogic worth (valuation)?

Valuation information for CoroLogic is not publicly available.

Can I buy CoroLogic stock?

CoroLogic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CoroLogic's last funding round?

CoroLogic's most recent funding round was Seed on September 14, 2026.

Who are the main investors in CoroLogic?

Key investors in CoroLogic include Kakao Ventures, Seoul National University Technology Holdings.

Will CoroLogic IPO soon?

No public IPO plans have been announced for CoroLogic.

How can I track CoroLogic secondary market activity?

Caplight tracks bids, offers, and trades in CoroLogic's shares on secondary markets.

Firmographic Details

HeadquartersSouth Korea
Year Founded2026
Last FundingSep 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?